Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Start of new week recap

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Mar 25, 2024 7:09pm

92 Views

Post# 35951811

RE:RE:RE:RE:RE:RE:Start of new week recap

Another great point Ionc17. Ramp up production so that we all think they may actually need additional doses of Pela for some reason.... and it's all chicanery!! There really is no chance of getting anything past you.

I bet you were a big murder she wrote fan and worked out the killer within the first few scenes. It's impressive.

<< Previous

Bullboard Posts

Next >>

Let's Invest: Are you prepared for do-it-yourself investing?